Medallia, Inc., the global leader in experience management, said that its cloud platform Crowdicity helps the UK-wide initiative to provide new solutions for the coronavirus spreading widely across the country. The UK Department of Health and Social Care in collaboration with the UK Bioindustry Association, the British In Vitro Diagnostics Association, and the Royal College of Pathologists, have taken a step-forward with Medallia’s crowdsourcing platform. The tool focuses on crowdsource ideas from a community of experts in order to meet the UK Government’s target of 100,000 coronavirus tests per day by the end of this month.

The platform started its operations from 10th April, naming it as #testingmethods2020. The major initiative is leveraging the Medallia Crowdicity platform to share best practices, gather innovative ideas, and agree on viable solutions to four key testing challenges. The response with over 100 solutions is already gathered and the number counting; this is targeted at pharmaceutical organizations, industry, academic institutions, health bodies, and existing testing labs. Additionally suggestions and comments are popping in from academics organisations and industries, and leading UK hospital trusts. Medallia which works with the NHS and the Department of Health and Social Care to drive innovation in patient experience has delivered this new crowdsourcing platform in less than 2 days’ time frame.

Medallia during early April has launched its “Take Care” Initiative, designed to help both public sector and private organizations through the disruption caused by the ongoing pandemic. Additionally to the #testingmethods2020 initiative, Medallia is also helping the Alzheimer’s Society, by enabling people living with dementia and their caretakers to share their unique challenges. Moreover the International Chamber of Commerce (ICC) and World Health Organisation (WHO) are using Medallia’s insight tools. This is to survey 45 million businesses to help combat Covid-19 business challenges.


Please enter your comment!
Please enter your name here